Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two doses three months apart.

Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA…

Japanese drugmaker Takeda's QDENGA has become India's first approved dengue vaccine, offering protection against all four virus serotypes without requiring pre-vaccination testing.

Takeda's QDENGA is India's first dengue vaccine approved for use regardless of prior exposure, enhancing disease prevention efforts.

India's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in India during the first half of 2027.…

País registrou mais de 1 milhão de casos desde 2021, com pelo menos 1.500 mortes